1. Warnakulasuriya S. Significant oral cancer risk associated with low socioeconomic status. Evid Based Dent 2009;10(1):4-5.
2. Brocklehurst PR, Baker SR, Speight PM. Oral cancer screening: what have we learnt and what is there still to achieve? Future Oncol 2010 Feb;6(2):299-304.
3. D’Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007 May;356(19):1944-1956.
4. Bosch FX, de Sanjosé S. The epidemiology of human papillomavirus infection and cervical cancer. Dis Markers 2007;23(4):213-227.
5. Chaudhary AK, Singh M, Sundaram S, Mehrotra R. Role of human papillomavirus and its detection in potentially malignant and malignant head and neck lesions: updated review. Head Neck Oncol 2009;1(1):22.
6. Tachezy R, Klozar J, Rubenstein L, Smith E, Saláková M, Smahelová J, et al. Demographic and risk factors in patients with head and neck tumors. J Med Virol 2009 May;81(5):878-887.
7. Silva KC, Rosa ML, Moyse N, Afonso LA, Oliveira LH, Cavalcanti SM. Risk factors associated with human papillomavirus infection in two populations from Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz 2009 Sep;104(6):885-891.
8. Hubbard RA. Human papillomavirus testing methods. Arch Pathol Lab Med 2003 Aug;127(8):940-945.
9. Brink AA, Snijders PJ, Meijer CJ. HPV detection methods. Dis Markers 2007;23(4):273-281.
10. Idris AM, Ahmed HM, Mukhtar BI, Gadir AF, el-Beshir EI. Descriptive epidemiology of oral neoplasms in Sudan 1970-1985 and the role of toombak. Int J Cancer 1995 Apr;61(2):155-158.
11. GLOBOCAN2002 [database on the Internet]. International Agency for Research on Cancer. Available from: http://www-dep.iarc.fr/ [last cited on 2010 May 5.
12. Osman TA, Satti AA, Bøe OE, Yang YH, Ibrahim SO, Suleiman AM. Pattern of malignant tumors registered at a referral oral and maxillofacial hospital in Sudan during 2006 and 2007. J Cancer Res Ther 2010 Oct-Dec;6(4):473-477.
13. Idris AM, Ibrahim SO, Vasstrand EN, Johannessen AC, Lillehaug JR, Magnusson B, et al. The Swedish snus and the Sudanese toombak: are they different? Oral Oncol 1998 Nov;34(6):558-566.
14. Idris AM, Ibrahim YE, Warnakulasuriya KA, Cooper DJ, Johnson NW, Nilsen R. Toombak use and cigarette smoking in the Sudan: estimates of prevalence in the Nile state. Prev Med 1998 Jul-Aug;27(4):597-603.
15. Elbeshir EI, Abeen HA, Idris AM, Abbas K. Snuff dipping and oral cancer in Sudan: a retrospective study. Br J Oral Maxillofac Surg 1989 Jun;27(3):243-248.
16. Idris AM, Prokopczyk B, Hoffmann D. Toombak: a major risk factor for cancer of the oral cavity in Sudan. Prev Med 1994 Nov;23(6):832-839.
17. Idris AM, Ahmed HM, Malik MO. Toombak dipping and cancer of the oral cavity in the Sudan: a case-control study. Int J Cancer 1995 Nov;63(4):477-480.
18. Ahmed HG, Mahgoob RM. Impact of Toombak dipping in the etiology of oral cancer: gender-exclusive hazard in the Sudan. J Cancer Res Ther 2007 Apr-Jun;3(2):127-130.
19. Idris AM, Ahmed HM, Mukhtar BI, Gadir AF, el-Beshir EI. Descriptive epidemiology of oral neoplasms in Sudan 1970-1985 and the role of toombak. Int J Cancer 1995 Apr;61(2):155-158.
20. Ahmed HG, Eltoom FM. Detection of Human Papilloma Virus Types 16 and 18 among Sudanese Patients with Oral Squamous Cell Carcinoma. The Open Cancer Journal 2010;3:130-134 .
21. Idris AM, Prokopczyk B, Hoffmann D. Toombak: a major risk factor for cancer of the oral cavity in Sudan. Prev Med 1994 Nov;23(6):832-839.
22. Ibrahim SO, Vasstrand EN, Johannessen AC, Idris AM, Magnusson B, Nilsen R, et al. Mutations of the p53 gene in oral squamous-cell carcinomas from Sudanese dippers of nitrosamine-rich toombak and non-snuff-dippers from the Sudan and Scandinavia. Int J Cancer 1999 May;81(4):527-534.
23. Ahmed HG, Idris AM, Ibrahim SO. Study of oral epithelial atypia among Sudanese tobacco users by exfoliative cytology. Anticancer Res 2003 Mar-Apr;23(2C):1943-1949.
24. Ahmed HG, Babiker AE. Assessment of cytological atypia, AgNOR and nuclear area in epithelial cells of normal oral mucosa exposed to toombak and smoking. Rare Tumors 2009;1(1):e18.
25. Ibrahim SO, Bertelsen B, Kalvenes MB, Idris AM, Vasstrand EN, Nilsen R, et al. Expression of keratin 13, 14 and 19 in oral squamous cell carcinomas from Sudanese snuff dippers: lack of association with human papillomavirus infection. APMIS 1998 Oct;106(10):959-969.
26. Pedrini JL, Pedrini M, Savaris RF, Machado L, Grudzinski M, Zettler CG. Reassessing tumor markers in local recurrences of breast cancer: a new insight. Med Sci Monit 2004 Dec;10(12):BR462-BR467.
27. Croce MV, Isla-Larrain M, Remes-Lenicov F, Colussi AG, Lacunza E, Kim KC, et al. MUC1 cytoplasmic tail detection using CT33 polyclonal and CT2 monoclonal antibodies in breast and colorectal tissue. Histol Histopathol 2006 Aug;21(8):849-855.
28. Anaya-Saavedra G, Ramírez-Amador V, Irigoyen-Camacho ME, García-Cuellar CM, Guido-Jiménez M, Méndez-Martínez R, et al. High association of human papillomavirus infection with oral cancer: a case-control study. Arch Med Res 2008 Feb;39(2):189-197.
29. Oliveira MC, Soares RC, Pinto LP, Souza LB, Medeiros SR, Costa AdeL. High-risk human papillomavirus (HPV) is not associated with p53 and bcl-2 expression in oral squamous cell carcinomas. Auris Nasus Larynx 2009 Aug;36(4):450-456.
30. Liang X, Lewis J, Foote R, Smith D, Kademani D. Prevalence and significance of human papillomavirus in oral tongue cancer: the Mayo Clinic experience. J Oral Maxillofac Surg. 2008 .66(9):1875-80.
31. Ahmed HG, Idris AM, Ibrahim SO. Study of oral epithelial atypia among Sudanese tobacco users by exfoliative cytology. Anticancer Res 2003 Mar-Apr;23(2C):1943-1949.
32. Idris, M., Prokopczy, B., Hoffmann, D. Toombak; A major risk factor for cancer of oral cavity in Sudan. 1999; 2 (61):155-158.
33. Ahmed HG, Mahgoob RM. Impact of Toombak dipping in the etiology of oral cancer: gender-exclusive hazard in the Sudan. J Cancer Res Ther 2007 Apr-Jun;3(2):127-130.
34. Skinner RL, Davenport WD Jr, Weir JC, Carr RF. Oral malignancy: a regional incidence observed over a 13-year period. South Med J 1985 Jun;78(6):652-656.
35. Chang F, Syrjãnen S, Kellokoski J, Syrjãnen K. Human papillomavirus (HPV) infections and their associations with oral disease. Journal Oral of Pathology. London. 1991; 316-326.
36. Syrjänen S. Human papilloma virus infections and oral tumors. Med Microbiol Immunol (Berl) 2003;32(1):59-66.
37. Gillison ML. Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 2004 Dec;31(6):744-754.
38. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92:675-677.
39. Ahmed HG, Eltoom FM. Detection of Human Papilloma Virus Types 16 and 18 among Sudanese Patients with Oral Squamous Cell Carcinoma. The Open Cancer Journal 2010;3:130-134 .
40. Bayat M. Epidemiological Study of Squamous Cell Carcinoma Patients Treated at Cancer Institute of Imam Khomeini Hospital from 1980 to 1992. Journal of Dental Medicine. Shahid Beheshti University of Medical Sciences 1999;17(3):168-175.
41. Köhler A, Lauritzen B, Van Noorden CJ. Signal amplification in immunohistochemistry at the light microscopic level using biotinylated tyramide and nanogold-silver staining. J Histochem Cytochem 2000 Jul;48(7):933-941.
|